Long; Yun Oliver

Patent Applications and Registrations

Patent applications and USPTO patent grants for Long; Yun Oliver.The latest application filed is for "inhibitors of kras g12c".

Company Profile

21.22.25

Long; Yun Oliver - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Kras G12c App 20220242875 - LI; Liansheng ; et al.	2022-08-04
Inhibitors Of Kras G12c App 20210188869 - LI; Liansheng ; et al.	2021-06-24
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof Grant 11,021,470 - Li , et al. June 1, 2	2021-06-01
Inhibitors of KRAS G12C mutant proteins Grant 10,975,071 - Li , et al. April 13, 2	2021-04-13
Substituted cinnolines as inhibitors of KRAS G12C Grant 10,927,125 - Li , et al. February 23, 2	2021-02-23
Inhibitors of KRAS G12C mutant proteins Grant 10,882,847 - Li , et al. January 5, 2	2021-01-05
Inhibitors of KRAS G12C mutant proteins Grant 10,875,842 - Li , et al. December 29, 2	2020-12-29
Inhibitors of KRAS G12C mutant proteins Grant 10,858,343 - Li , et al. December 8, 2	2020-12-08
Substituted quinazoline compounds and methods of use thereof Grant 10,829,458 - Li , et al. November 10, 2	2020-11-10
Inhibitors of KRAS G12C mutant proteins Grant 10,730,867 - Li , et al.	2020-08-04
Inhibitors of KRAS G12C mutant proteins Grant 10,723,738 - Li , et al.	2020-07-28
Inhibitors of KRAS G12C mutant proteins Grant 10,689,356 - Li , et al.	2020-06-23
2-substituted Quinazoline Compounds Comprising A Substituted Heterocyclic Group And Methods Of Use Thereof App 20200181123 - Li; Liansheng ; et al.	2020-06-11
Inhibitors of KRAS G12C mutant proteins Grant 10,647,703 - Li , et al.	2020-05-12
Substituted Quinazolines As Inhibitors Of Kras G12c App 20200102321 - LI; Liansheng ; et al.	2020-04-02
Inhibitors Of Kras G12c Mutant Proteins App 20200062761 - Li; Liansheng ; et al.	2020-02-27
Fused-tricyclic inhibitors of KRAS and methods of use thereof Grant 10,428,064 - Li , et al. October 1, 2	2019-10-01
Substituted Quinazoline Compounds And Methods Of Use Thereof App 20190284144 - Li; Liansheng ; et al.	2019-09-19
2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof Grant 10,414,757 - Li , et al. Sept	2019-09-17
Substituted quinolines as inhibitors of KRAS G12C Grant 10,370,386 - Li , et al.	2019-08-06
Substituted quinazoline compounds and methods of use thereof Grant 10,351,550 - Li , et al. July 16, 2	2019-07-16
Inhibitors of KRAS G12C mutant proteins Grant 10,280,172 - Li , et al.	2019-05-07
Substituted quinazoline compounds and methods of use thereof Grant 10,246,424 - Li , et al.	2019-04-02
Inhibitors Of Kras G12c Mutant Proteins App 20190092767 - Li; Liansheng ; et al.	2019-03-28
Inhibitors Of Kras G12c Mutant Proteins App 20190055211 - Li; Liansheng ; et al.	2019-02-21
Substituted quinazoline compounds and methods of use thereof Grant 10,144,724 - Li , et al. De	2018-12-04
Inhibitors Of Kras G12c Mutant Proteins App 20180319775 - LI; Liansheng ; et al.	2018-11-08
Inhibitors Of Kras G12c Mutant Proteins App 20180282307 - Li; Liansheng ; et al.	2018-10-04
Inhibitors Of Kras G12c Mutant Proteins App 20180282308 - Li; Liansheng ; et al.	2018-10-04
Inhibitors Of Kras G12c Mutant Proteins App 20180273515 - Li; Liansheng ; et al.	2018-09-27
Inhibitors Of Kras G12c Mutant Proteins App 20180273523 - Li; Liansheng ; et al.	2018-09-27
Substituted Quinazoline Compounds And Methods Of Use Thereof App 20180194748 - Li; Liansheng ; et al.	2018-07-12
Methods and compositions for inhibition of Ras Grant 10,011,600 - Li , et al. July 3, 2	2018-07-03
Inhibitors Of Kras G12c Mutant Proteins App 20180155348 - Li; Liansheng ; et al.	2018-06-07
Methods for preparation of quinazoline derivatives Grant 9,988,357 - Mani , et al. June 5, 2	2018-06-05
Substituted Quinazolines As Inhibitors Of Kras G12c App 20180118757 - Li; Liansheng ; et al.	2018-05-03
Fused-tricyclic Inhibitors Of Kras And Methods Of Use Thereof App 20180086753 - Li; Liansheng ; et al.	2018-03-29
Substituted quinazolines as inhibitors of KRAS G12C Grant 9,840,516 - Li , et al. December 12, 2	2017-12-12
Methods And Compositions For Inhibition Of Ras App 20170247376 - LI; Liansheng ; et al.	2017-08-31
2-substituted Quinazoline Compounds Comprising A Substituted Heterocyclic Group And Methods Of Use Thereof App 20170197945 - Li; Liansheng ; et al.	2017-07-13
Methods For Preparation Of Quinazoline Derivatives App 20170190672 - Mani; Neelakandha S. ; et al.	2017-07-06
Substituted Quinazoline Compounds And Methods Of Use Thereof App 20170022184 - Li; Liansheng ; et al.	2017-01-26
Substituted Quinazoline Compounds And Methods Of Use Thereof App 20160297774 - Li; Liansheng ; et al.	2016-10-13
Inhibitors Of Kras G12c App 20150239900 - Li; Liansheng ; et al.	2015-08-27
6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds Grant 7,816,372 - Zhi , et al. October 19, 2	2010-10-19
6-Cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds App 20080227810 - Zhi; Lin ; et al.	2008-09-18
6-Cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds App 20070066650 - Zhi; Lin ; et al.	2007-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.